Inventor · disambiguated record
Nunzio Bottini
Also filed as: BOTTINI NUNZIO
8 granted patents·12 pending applications·6 citations·filing 2002–2024
76Inventor score
Files withUNIV CALIFORNIA5BOTTINI NUNZIO2HOPE CITY2LA JOLLA INST ALLERGY & IMMUNOLOGY2LA JOLLA INST FOR IMMUNOLOGY2
Top patents by PatentIndex Score
20 records- 0183US10626094B2Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereofLA JOLLA INST OF ALLERGY & IMMUNOLOGY·Filed 2015·Granted Apr 21, 2020·5 cites·14 claims
- 0271US8034794B2Methods and compositions for acid phosphatase-1 gene inhibitionCOMINGS DAVID E·Filed 2010·Granted Oct 11, 2011·1 cites·4 claims
- 0369US12201598B2Immunoregulatory microparticles for modulating inflammatory arthritidesUNIV CALIFORNIA·Filed 2023·Granted Jan 21, 2025·0 cites·20 claims
- 0467US2025170086A1Immunoregulatory microparticles for modulating inflammatory arthritidesUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0565US2008241928A1Methods and compositions for acid phosphatase-1 gene inhibitionHOPE CITY·Filed 2008·Application pending·0 cites
- 0658US2025092156A1De-clustering inhibitors of ptpraUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0757US2005055732A1Acid phosphatase (acp1)gene as a susceptibility locus for hyperlipidemiaHOPE CITY·Filed 2002·Application pending·0 cites
- 0857US2022325261A1Ptprs and proteoglycans in autoimmune diseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0956US2025082734A1Ptprs in autoimmunityUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1054US11220486B2Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereofLA JOLLA INST OF ALLERGY & IMMUNOLOGY·Filed 2020·Granted Jan 11, 2022·0 cites·12 claims
- 1152US2015175979A1Ptprs and proteoglycans in autoimmune diseaseJOLLA INST ALLERGY IMMUNOLOG·Filed 2013·Application pending·0 cites
- 1251US8399213B2Method for monitoring intracellular tyrosine phosphatase activityBOTTINI NUNZIO·Filed 2009·Granted Mar 19, 2013·0 cites·6 claims
- 1343US2021393740A1Ptprs and proteoglycans in rheumatoid arthritisLA JOLLA INST FOR IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 1441US2020132673A1Proteoglycan irregularities in abnormal fibroblasts and therapies based therefromUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1540US11331388B1PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted May 17, 2022·0 cites·15 claims
- 1639US10604585B2Modulation of PTPRA to treat arthritisLA JOLLA INST FOR ALLERGY & IMMUNOLOGY·Filed 2015·Granted Mar 31, 2020·0 cites·11 claims
- 1739US10385340B2Autoimmune disease treatmentsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2015·Granted Aug 20, 2019·0 cites·7 claims
- 1839US2008199514A1Functional Variant of Lymphoid Tyrosine Phosphatase is Associated with Autoimmune DisordersBURNHAM INST·Filed 2005·Application pending·0 cites
- 1936US2013171164A1Compositions and methods of modulating receptor protein tyrosine phosphatasesBOTTINI NUNZIO·Filed 2012·Application pending·0 cites
- 2034US2010210836A1Small molecule inhibitors of lymphoid tyrosine phosphataseUNIV SOUTHERN CALIFORNIA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →